MEDIA CENTER

Conference link: http://techconnectworld.com/World2016/ "Oxy-17 LLC ", has been ACCEPTED to SHOWCASE its disruptive Nano-technology OxyFusion™ MRI medium at this year's TechConnect World Innovation Summit & Expo, co-located with the National Innovation Summit and National SBIR/STTR Conference, May 23-25, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD.

Rockland Technimed Ltd is a Theranostics company, committed to the early diagnosis and treatment of hypoxic injury. Rockland's disruptive Nano-technology OxyFusion™ MRI medium enriched with its patented Oxy-17® process may set the new Gold standard of Cellular metabolic imaging without radiotracers.

Hazards of Current Imaging Agent in Use:

Environmental hazard Reports of Gadolinium:

• U.S. Food and Drug Administration Information on Gadolinium-Based Contrast Agents • Health Canada Advises Canadians of Safety Issues Related to Gadolinium-Containing Contrast Agents Used in Magnetic Resonance Imaging (MRI) • UK Medicines and Healthcare products Regulatory Agency Drug Safety Update on Gadolinium-containing Contrast Agents: New Advice to Minimise the Risk of Nephrogenic Systemic Fibrosis • European Medicines Agency Makes Recommendations to Minimise Risk of Nephrogenic Systemic Fibrosis with Gadolinium-containing Contrast Agents